Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

12th International Conference on Myasthenia Gravis and Related Disorders
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent
MicroRNAs: The Role in Autoimmune Inflammation.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Decision making under uncertainty, therapeutic inertia, and physicians' risk preferences in the management of multiple sclerosis (DIScUTIR MS).
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation.
The use of hematopoietic stem cells in autoimmune diseases.
Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Myelin Basic Protein Citrullination in Multiple Sclerosis: A Potential Therapeutic Target for the Pathology.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Influence of infection on exacerbations of multiple sclerosis.
Women's Issues in Multiple Sclerosis.
Regulation of dimethyl-fumarate toxicity by proteasome inhibitors.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
Rebound Relapses After Ceasing Another Disease-Modifying Treatment in Patients With Multiple Sclerosis: Are There Lessons to Be Learned?
World Congress of Neurology (WCN) 2015
Glatiramer acetate increases phagocytic activity of human monocytes in vitro and in multiple sclerosis patients.

Pages